Replies to post #76443 on Biotech Values

[gym gravity]

how long before an oral HCV cocktail pill?

"IDX316 retained activity against common mutations in NS3 and exhibited enhanced activity when combined with standard-of-care agents or other Idenix compounds in development (IDX184 and IDX375). Favorable PK profiles in rodent and non-human primate species suggest the potential for once- or twice-daily dosing in humans (half-life of 4.0-5.2 h; bioavailability of ~20%)."

[DewDiligence]

IDIX – EASL posters for IDX136/316 and IDX375, respectively:

http://www.idenix.com/hepc/drug/IDXPI_Poster_(handout)_Final_EASL09.pdf

http://www.idenix.com/hepc/drug/IDX375_Poster_(handout)_Final_EASL09.pdf